Epidemiology of respiratory syncytial virus in children ≤2 years of age hospitalized with lower respiratory tract infections in the Russian Federation: a prospective, multicenter study

@inproceedings{Tatochenko2010EpidemiologyOR,
  title={Epidemiology of respiratory syncytial virus in children ≤2 years of age hospitalized with lower respiratory tract infections in the Russian Federation: a prospective, multicenter study},
  author={Vladimir Tatochenko and Vasily F Uchaikin and Aleksandr Gorelov and Konstantin M Gudkov and Andrew M Campbell and Gregory Alan Schulz and Rebecca Prahl and Gerard F Notario},
  booktitle={Clinical epidemiology},
  year={2010}
}
BACKGROUND Respiratory syncytial virus (RSV) is the leading cause of severe lower respiratory tract infections among infants and young children, and is responsible for an estimated four million deaths per year globally. A monthly injection of palivizumab has been used for prophylaxis of serious RSV infections among high-risk children in 71 countries since 1998 and approval for use in the Russian Federation was obtained in February 2010. A recommendation for RSV prophylaxis in the Russian… CONTINUE READING
10 Citations
32 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 32 references

Similar Papers

Loading similar papers…